Summary of 2017 ESC guidelines on valvular heart disease, peripheral artery disease, STEMI and on dual antiplatelet therapy
(2017) Acta Cardiologica : an international journal of cardiology — Vol. Dec, p. 1-7 (2017)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- During the ESC congress in September 2017 in Barcelona, the new ESC guidelines were presented and are now available on the ESC website. The new guidelines cover management recommendations on following cardiovascular items: valvular heart disease, peripheral artery disease, ST elevation myocardial infarction (STEMI) and on dual antiplatelet therapy. The present document gives a summary of these guidelines and highlights the most important recommendations and changes in the management of these diseases. It will help to increase awareness about the new guidelines and may stimulate to consult the full document for specific items. Ultimately, the authors hope that this document will enhance implementation of new ESC guidelines in daily clinical practice.
- Affiliations
Citations
Van Camp, G., De Backer, T., Beauloye, C., Desmet, W., & Claeys, M. J. (2017). Summary of 2017 ESC guidelines on valvular heart disease, peripheral artery disease, STEMI and on dual antiplatelet therapy. Acta Cardiologica : an international journal of cardiology, Dec, 1-7. https://doi.org/10.1080/00015385.2017.1410352 (Original work published 2017)